ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novo Nordisk resumes late-stage haemophilia trials
August 17, 2020Novo Nordisk is set to resume the phase 3 clinical trials of concizumab in haemophilia A and B, with or without inhibitors, following a previous safety scare. -
Concizumab haemophilia trials paused over safety concerns
March 19, 2020The occurrence of non-fatal thrombotic events in Phase III study participants has called into question the safety of concizumab. -
Novo cancels haemophilia drug Phase III trial
March 18, 2020Novo Nordisk has paused the Phase III explorer7 and explorer8 trials for haemophilia drug concizumab, due to non-fatal thrombotic events, the company says.
Pharma Sources Insight January 2025
